Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Hochster, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 30 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Giantonio, BJ; Hochster, H; Blum, R; Wiernik, PH; Hudes, GR; Kirkwood, J; Trump, D; Oken, MM
      Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: A report of two clinical trials of the Eastern Cooperative Oncology Group

      INVESTIGATIONAL NEW DRUGS
    2. Ng, B; Kramer, E; Liebes, L; Wasserheit, C; Hochster, H; Blank, E; Ceriani, R; Furmanski, P
      Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts

      CANCER RESEARCH
    3. Liebes, L; Conaway, CC; Hochster, H; Mendoza, S; Hecht, SS; Crowell, J; Chung, FL
      High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: Application to studies with 2-phenethyl isothiocyanate

      ANALYTICAL BIOCHEMISTRY
    4. Schilsky, RL; Bukowski, R; Burris, H; Hochster, H; O'Rourke, M; Wall, JG; Mani, S; Bonny, T; Levin, J; Hohneker, J
      A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer

      ANNALS OF ONCOLOGY
    5. Mani, S; Hochster, H; Beck, T; Chevlen, EM; O'Rourke, MA; Weaver, CH; Bell, WN; White, R; McGuirt, C; Levin, J; Hohneker, J; Schilsky, RL; Lokich, J
      Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancer

      JOURNAL OF CLINICAL ONCOLOGY
    6. Cooper, JS; Lee, H; Torrey, M; Hochster, H
      Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: Preliminary corroboration of the intergroup experience

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    7. Rosenthal, MA; Gruber, ML; Glass, J; Nirenberg, A; Finlay, J; Hochster, H; Muggia, FM
      Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme

      JOURNAL OF NEURO-ONCOLOGY
    8. Kiremidjian-Schumacher, L; Roy, M; Glickman, R; Schneider, K; Rothstein, S; Cooper, J; Hochster, H; Kim, M; Newman, R
      Selenium and immunocompetence in patients with head and neck cancer

      BIOLOGICAL TRACE ELEMENT RESEARCH
    9. Wadler, S; Schwartz, EL; Anderson, P; Runowicz, CD; Chuang, L; Del Priore, G; Hochster, H; Goldberg, G; Fields, A; Loewen, G; Haynes, H
      Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    10. Hochster, H; Strawderman, MH; Harris, JE; Atkins, MB; Oken, M; Skeel, RT; Jubelirer, SJ; Parkinson, D
      Conventional dose melphalan is inactive in metastatic melanoma: results ofan Eastern Cooperative Oncology Group Study (E1687)

      ANTI-CANCER DRUGS
    11. Vogel, C; O'Rourke, M; Winer, E; Hochster, H; Chang, A; Adamkiewicz, B; White, R; McGuirt, C
      Vinorelbine as first-line chemotherapy for advanced breast cancer in women60 years of age or older

      ANNALS OF ONCOLOGY
    12. Hochster, H; Wadler, S; Runowicz, C; Liebes, L; Cohen, H; Wallach, R; Sorich, J; Taubes, B; Speyer, J
      Activity and pharmacodynamics of 21-day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy

      JOURNAL OF CLINICAL ONCOLOGY
    13. Kucuk, O; Pandya, KJ; Skeel, RT; Hochster, H; Abeloff, MD
      Phase II study of cisplatin and 5-fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185)

      BREAST CANCER RESEARCH AND TREATMENT
    14. Hochster, H; Speyer, JL; Mandeli, JP; Runowicz, C; Wadler, S; Berk, G; Wallach, R; Holland, JF
      A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer

      GYNECOLOGIC ONCOLOGY
    15. VOKES EE; FIGLIN R; HOCHSTER H; LOTZE M; RYBAK ME
      A PHASE-II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-4 FOR ADVANCED OR RECURRENT NONSMALL CELL LUNG-CANCER

      The cancer journal from Scientific American
    16. LIEBES L; POTMESIL M; KIM T; PEASE D; BUCKLEY M; FRY D; CHO J; ADLER H; DAR K; ZELENIUCHJACQUOTTE A; HOCHSTER H
      PHARMACODYNAMICS OF TOPOISOMERASE-I INHIBITION - WESTERN-BLOT DETERMINATION OF TOPOISOMERASE-I AND CLEAVABLE COMPLEX IN PATIENTS WITH UPPERGASTROINTESTINAL MALIGNANCIES TREATED WITH TOPOTECAN

      Clinical cancer research
    17. LIEBES L; POTMESIL M; KIM T; PEASE D; BUCKLEY M; FRY D; CHO J; ADLER H; DAR K; ZELENIUCHJACQUOTTE A; HOCHSTER H
      PHARMACODYNAMICS OF TOPOISOMERASE-I INHIBITION - WESTERN-BLOT DETERMINATION OF TOPOISOMERASE-I AND CLEAVABLE COMPLEX IN PATIENTS WITH UPPERGASTROINTESTINAL MALIGNANCIES TREATED WITH TOPOTECAN

      Clinical cancer research
    18. SCHILSKY R; BUKOWSKI R; ROWINSKY E; BURRIS H; CRAWFORD J; HOCHSTER H; OROURKE M; GLENDENNING A; BARTON C
      ORAL 5-FLUOROURACIL (5-FU) PLUS ENILURACIL (776C85) IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - A QUALITY-OF-LIFE (QOL) EVALUATION

      Annals of oncology
    19. LOKICH J; BECK T; CHEVLEN E; HOCHSTER H; OROURKE M; WEAVER C; BELL W; MCGUIRT C; LEVIN J; HOHNEKER J; MANI S
      A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY REGIMEN OF ORAL 5-FLUOROURACIL (5-FU) PLUS 776C85 FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL-CANCER (CRC)

      Annals of oncology
    20. Hochster, H; Oratz, R; Ettinger, DS; Borden, E
      A phase II study of Didemnin B (NSC 325319) in advanced malignant melanoma: an Eastern Cooperative Oncology Group study (PB687)

      INVESTIGATIONAL NEW DRUGS
    21. HOCHSTER H; LIEBES L; SPEYER J; SORICH J; TAUBES B; ORATZ R; WERNZ J; CHACHOUA A; BLUM RH; ZELENIUCHJACQUOTTE A
      EFFECT OF PROLONGED TOPOTECAN INFUSION ON TOPOISOMERASE-1 LEVELS - A PHASE-I AND PHARMACODYNAMIC STUDY

      Clinical cancer research
    22. HOCHSTER H; CHACHOUA A; SORICH J; WASSERHEIT C; TAUBES B; FRIEDBERG A; ARBUCK S; SPEYER J
      PHASE-I STUDY OF PACLITAXEL(P) COMBINED WITH 14-DAY TOPOTECAN(T) CONTINUOUS IV (CIV) INFUSION IN PREVIOUSLY TREATED AND UNTREATED PATIENTS (PTS)

      European journal of cancer
    23. NG B; LIEBES L; KRAMER EL; WASSERHEIT C; HOCHSTER H; BLANK E; CERIANI R; FURMANSKI P
      SYNERGISTIC ACTIVITY OF RADIOIMMUNOTHERAPY WITH Y-90 MX-DTPA HUBRE-3 AND PROLONGED TOPOTECAN INFUSION IN HUMAN BREAST-CANCER XENOGRAFTS

      The Journal of nuclear medicine
    24. VANHOEVEN KH; ANYAEGBUNAM A; HOCHSTER H; WHITTY JE; DISTANT J; CRAWFORD C; FACTOR SM
      CLINICAL-SIGNIFICANCE OF INCREASING HISTOLOGIC SEVERITY OF ACUTE-INFLAMMATION IN THE FETAL MEMBRANES AND UMBILICAL-CORD

      PEDIATRIC PATHOLOGY & LABORATORY MEDICINE
    25. WASSERHEIT C; FRAZEIN A; ORATZ R; SORICH J; DOWNEY A; HOCHSTER H; CHACHOUA A; WERNZ J; ZELENIUCHJACQUOTTE A; BLUM R; SPEYER J
      PHASE-II TRIAL OF PACLITAXEL AND CISPLATIN IN WOMEN WITH ADVANCED BREAST-CANCER - AN ACTIVE REGIMEN WITH LIMITING NEUROTOXICITY

      Journal of clinical oncology
    26. RUNOWICZ CD; MANDELI J; SPEYER JL; WADLER S; HOCHSTER H; GARRISON L; HOLLAND JF
      PHASE I II STUDY OF PIXY321 IN COMBINATION WITH CYCLOPHOSPHAMIDE AND CARBOPLATIN IN THE TREATMENT OF OVARIAN-CANCER/

      American journal of obstetrics and gynecology
    27. SPEYER JL; MANDELI J; HOCHSTER H; RUNOWICZ CD; WADLER S; WALLACH R; COHEN C; OETTE D; SORICH J; DEMAKOS E; GELPKE L; GOLDBERG G; BRUCKNER H; HOLLAND J
      A PHASE-I TRIAL OF CYCLOSPHOSPHAMIDE AND CARBOPLATINUM COMBINED WITH INTERLEUKIN-3 IN WOMEN WITH ADVANCED-STAGE OVARIAN-CANCER

      Gynecologic oncology
    28. HOCHSTER H; LIEBES L; SPEYER J; SORICH J; TAUBES B; ORATZ R; WERNZ J; CHACHOUA A; RAPHAEL B; VINCI RZ; BLUM RH
      PHASE-I TRIAL OF LOW-DOSE CONTINUOUS TOPOTECAN INFUSION IN PATIENTS WITH CANCER - AN ACTIVE AND WELL-TOLERATED REGIMEN

      Journal of clinical oncology
    29. HOCHSTER H; OKEN M; BENNETT J; WOLF B; GORDON L; RAPHAEL B; GENCARELLI P; CASSILETH P
      EFFICACY OF CYCLOPHOSPHAMIDE (CYC) AND FLUDARABINE (FAMP) AS 1ST LINETHERAPY OF LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) - ECOG 1491

      Blood
    30. WADLER S; HAYNES H; BEITLER JJ; GOLDBERG G; HOLLAND JF; HOCHSTER H; BRUCKNER H; MANDELI J; SMITH H; RUNOWICZ C
      MANAGEMENT OF HYPOCALCEMIC EFFECTS OF WR2721 ADMINISTERED ON A DAILY TIMES 5 SCHEDULE WITH CISPLATIN AND RADIATION-THERAPY

      Journal of clinical oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 09:24:02